This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Philips recalled several models of its Trilogy ventilators ...
FDA today identified Philips Respironics Trilogy Evo continuous ventilator recall as Class I, over a month after the company initiated the voluntary correction in March. The ventilators affected by ...
(RTTNews) - Philips Respironics, affiliated to Dutch consumer electronics giant, announced additional usage instructions for Trilogy Evo Ventilators related to use of in-line nebulizers. The company ...
On Tuesday, Koninklijke Philips N.V. (NYSE:PHG) issued a correction related to the Software Version used in Trilogy Evo, Trilogy EV300, Trilogy Evo O2, and Trilogy Evo Universal ventilators to resolve ...
The U.S. Food and Drug Administration (FDA) has ordered a software recall for a type of ventilator, for fear of "serious injuries or death." The ventilators—the Philips Respironics, Inc. Trilogy EVO, ...
Philips Respironics recently announced a mandatory software correction and updates to its instructions for use (IFU) for the Trilogy Evo, EV300, Evo02, and Evo Universal ventilators to resolve several ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback